NCT00310479View on ClinicalTrials.gov

Clinico-pathologic Correlative Study of 3T Magnetic Resonance Spectroscopy in the Localization of Prostate Cancer

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Prostate Cancer
Interventions
DEVICE

Magnetic Resonance Spectroscopy (3Tesla)

Trial Locations (1)

T6G 1Z2

Cross Cancer Institute, Edmonton

All Listed Sponsors
collaborator

Cross Cancer Institute

OTHER

lead

AHS Cancer Control Alberta

OTHER

NCT00310479 - Clinico-pathologic Correlative Study of 3T Magnetic Resonance Spectroscopy in the Localization of Prostate Cancer | Biotech Hunter | Biotech Hunter